gm ct DeSci's Q4 alpha just lit up with @BioProtocol dropping the BioAgents framework open-source, packing x402 payments and modular tools that let AI bots fund their own hypothesis sprints without the grant grind This flips the script on biotech R&D: agents pulling genomic data, running sims, and routing royalties back to DAOs in real-time, no middlemen choking the flow What's stacking now → Staking upgrades hitting 1.5x XP multipliers for $BIO lockers, 125M already in across chains, APY cruising 15-20% ahead of Nov 15 Season 2 drop → VitaSTEM Ignition Sale pulling 13.5x FDV vibes from eDMT's Rogan glow-up, men's health AI via D1ckGPT next in queue for $50K-250K researcher grants → Aave borrow/lend proposal live, veBIO votes locking in liquidity plays while whales scoop 10% more post-Sep dip At $0.172 and $287M cap, $BIO's trading like DeSci's still bootstrapping TVL at $150M, 3.7K holders, 10K+ daily txns, 27% MoM buzz on tokenized trials Pipeline catalysts → Nov 6 webinar with CSO Sinka and Perlstein unpacking blockchain funding chaos, RSVP heat building → dLAB beta Q4 for smart ring ECG data onchain, Samsung ultrasound flows incoming → Solana staking Dec, cross-chain IP bridges Q1 '26 targeting 500 BioDAOs by year-end Permissionless science factory's revving, capital chasing milestones over VC drag who's staking for the airdrop alpha before Nov 15 #DeSci $BIO @BioProtocol
1,300
9
本頁面內容由第三方提供。除非另有說明,OKX 不是所引用文章的作者,也不對此類材料主張任何版權。該內容僅供參考,並不代表 OKX 觀點,不作為任何形式的認可,也不應被視為投資建議或購買或出售數字資產的招攬。在使用生成式人工智能提供摘要或其他信息的情況下,此類人工智能生成的內容可能不準確或不一致。請閱讀鏈接文章,瞭解更多詳情和信息。OKX 不對第三方網站上的內容負責。包含穩定幣、NFTs 等在內的數字資產涉及較高程度的風險,其價值可能會產生較大波動。請根據自身財務狀況,仔細考慮交易或持有數字資產是否適合您。